Change in SDS height-for-age between baseline and 52 weeks
| First-line IFX (n=48) | Conventional (n=47) | P value | |
| SDS height for age at baseline, median (IQR) | −0.07 (−0.84 to 0.76) | −0.53 (−1.06 to 0.26) | 0.069 |
| SDS height for age at week 52, median (IQR) | 0.02 (−0.81 to 0.70) | −0.66 (−1.13 to 0.11) | 0.021 |
| Change in SDS height-for-age between baseline and 52 weeks | 0.08 (−0.05 to 0.21) | −0.08 (−0.23 to 0.04) | 0.002 |
| Median increase in height (cm) between baseline and 52 weeks | 4.0 (1.1–6.2) | 2.4 (0.7–5.4) | 0.226 |
IFX, infliximab; SDS, SD score.